|
Swiss biotech AC Immune discusses its PET tracer's potential in realising precision medicine approaches to neurodegenerative diseases.
|
 |
|
Neuromodulation is an adjunct to medication for Parkinson’s symptom management, with growing interest in whether it could one day contribute to disease-modifying therapies.
|
|
|
The agreement gives Motif Neurotech access to MintNeuro’s miniaturised sensing and stimulation integrated circuits.
|
|
|
GE HealthCare has cut its 2026 growth outlook by 3.3% at the top end, citing increasing freight costs for oil and other materials.
|
|
|
The funds will advance Axoft’s existing clinical trial programmes and progress US regulatory activities for its implantable brain-computer interface.
|
|
|
CareDx’s plans to acquire Naveris follow the divestment of its lab products business earlier this month, reporting flat revenue for the segment in Q1.
|
|
